Collectively, these findings demonstrate that CD207<sup>+</sup> DCs orchestrate a pathogenic CD8<sup>+</sup> T-cell response in emphysema and represent a promising therapeutic target. The gene discussed is CD207; the disease is pulmonary emphysema.